These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7535073)

  • 21. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
    Pedrazzoli P; Gibelli N; Pavesi L; Preti P; Piolini M; Bertolini F; Robustelli della Cuna G
    Anticancer Res; 1996; 16(4A):1781-5. PubMed ID: 8712701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.
    Höglund M; Smedmyr B; Simonsson B; Tötterman T; Bengtsson M
    Bone Marrow Transplant; 1996 Jul; 18(1):19-27. PubMed ID: 8831991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human serum inactivates non-glycosylated but not glycosylated granulocyte colony stimulating factor by a protease dependent mechanism: significance of carbohydrates on the glycosylated molecule.
    Carter CR; Keeble JR; Thorpe R
    Biologicals; 2004 Mar; 32(1):37-47. PubMed ID: 15026024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
    Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
    Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
    Takemoto Y; Wada H; Takatsuka H; Okamoto T; Kakishita E
    Drugs Exp Clin Res; 2000; 26(1):1-5. PubMed ID: 10761530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPGN type I induced by granulocyte colony stimulating factor.
    Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I
    Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.
    Lachaux A; Boillot O; Stamm D; Canterino I; Dumontet C; Regnier F; Floret D; Hermier M
    J Pediatr; 1993 Dec; 123(6):1005-8. PubMed ID: 7693904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.
    Mattii L; Azzarà A; Fazzi R; Carulli G; Chimenti M; Cecconi N; Galimberti S; Petrini M
    Leuk Res; 2005 Nov; 29(11):1285-92. PubMed ID: 15916805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells.
    Querol S; Cancelas JA; Amat L; Capmany G; Garcia J
    Haematologica; 1999 Jun; 84(6):493-8. PubMed ID: 10366791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group.
    Donadieu J; Boutard P; Bernatowska E; Tchernia G; Couillaud G; Philippe N; Le Gall E
    Eur J Pediatr; 1997 Sep; 156(9):693-700. PubMed ID: 9296532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.
    Dunn CJ; Goa KL
    Drugs; 2000 Mar; 59(3):681-717. PubMed ID: 10776839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM).
    Takagi T; Sawamura M; Sezaki T; Kashimura M; Tsuchiya J; Hotta T; Ogawa N; Hirashima K
    Support Care Cancer; 2001 Jul; 9(5):397-9. PubMed ID: 11497396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
    Hellmich B; Schnabel A; Gross WL
    Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recombinant human granulocyte colony-stimulating factor (G-CSF)].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):541-9. PubMed ID: 7680849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.